Ketoprofen and Neoplasm progression - a phase IV clinical study of FDA data

Summary:

Neoplasm progression is reported as a side effect among people who take Ketoprofen (ketoprofen), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Afinitor, and have Constipation.

The phase IV clinical study analyzes which people have Neoplasm progression when taking Ketoprofen. It is created by eHealthMe based on reports of 14,955 people who have side effects when taking Ketoprofen from the FDA, and is updated regularly.

What is Ketoprofen?

Ketoprofen has active ingredients of ketoprofen. It is often used in pain. eHealthMe is studying from 15,048 Ketoprofen users. Check the latest studies of Ketoprofen.

What is Neoplasm progression?

Neoplasm progression (growth of tumour) is found to be associated with 1,069 drugs and 912 conditions by eHealthMe. Check the latest studies of Neoplasm progression.

On Jul, 09, 2026

14,955 people reported to have side effects when taking Ketoprofen.
Among them, 26 people (0.17%) have Neoplasm progression.

Could Ketoprofen cause Neoplasm progression?

Among these 26 people:

How long have people been on Ketoprofen when they have Neoplasm progression? *

What is the gender of people who have Neoplasm progression when taking Ketoprofen? *

female: 73.08 %
male: 26.92 %

What is the age of people who have Neoplasm progression when taking Ketoprofen? *

What are other drugs people take besides Ketoprofen? *

What are other side effects people have besides Neoplasm progression? *

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 15 people, 57.69%
Weight Decreased: 14 people, 53.85%
Constipation: 14 people, 53.85%
Abdominal Pain Upper: 13 people, 50.00%
Diarrhea: 13 people, 50.00%
Nausea And Vomiting: 13 people, 50.00%
Oedema Peripheral (superficial swelling): 12 people, 46.15%
Weakness: 12 people, 46.15%
Hypoaesthesia (reduced sense of touch or sensation): 12 people, 46.15%
Faeces Discolored: 12 people, 46.15%

What are the existing conditions these people have? *

Constipation: 13 people, 50.00%
Thrombosis (formation of a blood clot inside a blood vessel): 12 people, 46.15%
Pancreatic Neuroendocrine Tumor Metastatic: 12 people, 46.15%
Calcium Deficiency (lack of calcium): 12 people, 46.15%
Pvt: 11 people, 42.31%
Depression: 11 people, 42.31%
Inflammation: 11 people, 42.31%
Back Pain: 11 people, 42.31%
Neuralgia (pain in one or more nerves): 11 people, 42.31%
Pancreatic Neuroendocrine Tumor: 5 people, 19.23%

* Approximation only. Some reports may have incomplete information.

Do you take Ketoprofen and have Neoplasm progression?

- Check whether Neoplasm progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ketoprofen:

Ketoprofen (15,048 reports)

Browse all side effects of Ketoprofen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neoplasm progression:

Neoplasm progression (1,069 drugs)

Browse all the conditions that are associated with Neoplasm progression:

Neoplasm progression (912 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ketoprofen (the active ingredients of Ketoprofen) and Ketoprofen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.